AYTU licensed exclusive rights to the Healight technology from Cedars-Sinai. According to the company. The company said they believe “Healight platform technology has the potential to positively impact outcomes for critically ill patients infected with coronavirus and other infections”. The Uv light is inserted into the lungs via a breathing tube in order to kill bacteria and viruses.
According to the company “These findings suggest that UVA therapy can potentially provide a safe and effective novel approach to antimicrobial treatment via phototherapy on internal organs”. They are working with the FDA to fast track approval in order to fight Covid 19 on a more massive scale.